M. Ebert

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme

Markus Moehler, Annett Maderer, C Schimanski et al. · European Journal of Cancer · 2014 · 135 citations · Full text

Medicine, Oncology, Pharmacology +11

Her2/neu testing in gastric cancer: evaluating the risk of sampling errors

Viktoria S. Warneke, H.-M. Behrens, Christine Böger et al. · Annals of Oncology · 2012 · 135 citations · Full text

Medicine, Oncology, Pathology +17

Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen inKRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study

Beate Schultheis, Dirk Reuter, M. Ebert et al. · Annals of Oncology · 2017 · 124 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Hypoxia-inducible factor-1α expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas

Ewen A. Griffiths, Susan Pritchard, Helen Valentine et al. · British Journal of Cancer · 2006 · 107 citations · Full text

Medicine, Oncology, Pathology +15

Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application

Amelie Echle, Narmin Ghaffari Laleh, Philip Quirke et al. · ESMO Open · 2022 · 107 citations · Full text

Medicine, Genetics, Oncology +17